HealthcareServices

Aortic Stenosis Market 2026–2030: Forecasting Business Opportunities Ahead

February 19, 2026February 19, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the aortic stenosis market from 2026–2035 with trusted insights from The Business Research Company

How much is the Aortic Stenosis Market valued at in 2026, and what valuation is forecast for 2030?

The market size for aortic stenosis has experienced swift expansion in recent years. This market is projected to expand from $8.91 billion in 2025 to reach $10.06 billion by 2026, achieving a compound annual growth rate (CAGR) of 12.9%. Historically, this expansion is linked to factors such as the world’s aging populace, a rise in degenerative heart valve disease cases, the growth of cardiac catheterization facilities, enhanced surgical valve replacement procedures, and heightened clinical knowledge of valvular issues.

The aortic stenosis market is projected to experience substantial growth in the upcoming years. Its valuation is anticipated to reach $16.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. This expansion during the forecast period is fueled by factors such as enhanced investments in advanced valve technologies, a surge in the adoption of TAVR procedures, the broadening of outpatient cardiac care frameworks, a heightened emphasis on early intervention approaches, and the increasing incorporation of digital cardiac monitoring solutions. Key trends observed within this period encompass the growing acceptance of transcatheter valve replacement procedures, a heightened need for less invasive cardiac interventions, the expanded utilization of sophisticated diagnostic imaging, the development of customized valve therapy options, and an intensified focus on identifying diseases early.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21102&type=smp

What Drivers Are Influencing The Growth Of The Aortic Stenosis Market?

The expanding occurrence of heart conditions is anticipated to fuel the expansion of the aortic stenosis market in the future. Heart conditions encompass various ailments that compromise the heart’s structure and its operational capabilities. Such conditions may hinder the heart’s efficiency in pumping blood, resulting in adverse effects. Typical heart diseases include coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, and cardiomyopathy, among others. Aortic stenosis is characterized by a constriction of the aortic valve, obstructing blood flow from the left ventricle into the aorta. This heightened resistance compels the heart to exert more effort, potentially culminating in heart failure and other long-term cardiovascular issues. Effective management of aortic stenosis, through interventions like valve replacement or TAVI, aids in enhancing cardiac performance and mitigating the likelihood of severe heart disease consequences. For example, data from January 2025, provided by the British Heart Foundation, a UK-based charity focused on cardiovascular research, indicates that approximately 7.6 million individuals in the UK are afflicted with heart and circulatory diseases, comprising roughly 4 million males and 3.6 million females. These ailments are responsible for approximately 27% of all mortalities in the UK, causing more than 170,000 fatalities each year, which translates to 480 deaths per day. Consequently, the rising occurrence of heart diseases is propelling the expansion of the aortic stenosis market.

What Segments Are Included Within The Aortic Stenosis Market?

The aortic stenosis market covered in this report is segmented –

1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis

2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty

3) By End User: Hospitals and Cardiac Centers, Ambulatory Surgical Centers, Cardiac Surgeons and Interventional Cardiologists

Subsegments:

1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis

2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis

Which Market Trends Are Opening Growth Opportunities In The Aortic Stenosis Market?

Leading companies in the aortic stenosis market are concentrating on developing innovative aortic valve technologies, such as transcatheter aortic valve implantation (TAVI) systems, with the aim of enhancing patient outcomes, minimizing procedural risks, and improving the overall effectiveness of aortic treatment. The transcatheter aortic valve implantation (TAVI) system is a minimally invasive medical device capable of replacing a diseased aortic valve without requiring open-heart surgery. For instance, in January 2023, Abbott Laboratories, a US-based medical device company, obtained approval from the U.S. Food and Drug Administration (FDA) for Navitor, its latest-generation transcatheter aortic valve implantation (TAVI) system. Navitor incorporates the NaviSeal fabric cuff, which works to reduce or eliminate paravalvular leaks. The system’s design, featuring leaflets positioned within the native valve, seeks to improve access to coronary arteries for future treatments of coronary artery disease.

Who Are The Prominent Global Companies Shaping The Aortic Stenosis Market Landscape?

Major companies operating in the aortic stenosis market are Abbott Laboratories, Medtronic plc, Edwards Lifesciences Corporation, Boston Scientific Corporation, Terumo Corporation, LivaNova PLC, CryoLife Inc, Anteris Technologies Ltd, Venus Medtech, Peijia Medical, MicroPort Scientific Corporation, Lepu Medical Technology Co Ltd, Symetis SA, Artivion Inc, HighLife SAS, Transcatheter Technologies GmbH, NaviGate Cardiac Structures Inc, Xeltis BV, Sorin Group, Meril Life Sciences Pvt Ltd, On-X Life Technologies Inc, Braile Biomédica, Colibri Heart Valve

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Aortic Stenosis Market?

North America was the largest region in the aortic stenosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stenosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Aortic Stenosis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21102&type=smp

Browse Through More Reports Similar to the Global Aortic Stenosis Market 2026, By The Business Research Company

Vascular Stent Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Aortic Endograft Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-endograft-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795